GFAP and Alzheimer disease: We examined how different bloodpressure metrics associated with molecular markers of astrocytic activation (GFAP),neuronal axon breakdown (NfL), and Alzheimer’s disease pathobiology (pTau181,Aβ42/40) in plasma.